Yiyi fuzi baijiang decoction alleviates ulcerative colitis partly by regulating tlr4-mediated pi3k/akt and nf- κ b pathways

HIGHLIGHTS

• who: Yiyi Fuzi Baijiang Decoction et al. from the Department of Gastroenterology, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, China have published the paper: Yiyi Fuzi Baijiang Decoction Alleviates Ulcerative Colitis Partly by Regulating TLR4-Mediated PI3K/Akt and NF- κ B Pathways, in the Journal: Evidence-Based Complementary and Alternative Medicine of 15/02/2022
• what: This study was designed to explore the potential mechanism of YFBD in treating UC. This study evaluated the protein expression in the pathways using WB.
• how: Dextran sulfate sodium- (DSS-) induced mice and . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.